Alignment Healthcare (ALHC)
(Delayed Data from NSDQ)
$12.97 USD
-0.81 (-5.88%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $12.96 -0.01 (-0.08%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth B Momentum A VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
ALHC 12.97 -0.81(-5.88%)
Will ALHC be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ALHC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ALHC
Are Medical Stocks Lagging Akebia Therapeutics (AKBA) This Year?
Clover Health Pre-Q2 Earnings Analysis: Buy, Sell or Hold the Stock?
ALHC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Alignment Healthcare (ALHC) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Alignment Healthcare (ALHC) Q2 Earnings and Revenues Surpass Estimates
Alignment Healthcare (ALHC) Upgraded to Buy: Here's What You Should Know
Other News for ALHC
Alignment Healthcare (ALHC) Receives Upgrade Amid Valuation Concerns
Barclays Boosts Alignment Healthcare (ALHC) Price Target and Rating
Barclays upgrades Alignment to Equal Weight on reduced risk
Barclays gets more bullish on Alignment Healthcare, upgrades shares
12 Health Care Stocks Moving In Thursday's Pre-Market Session